Maolin Jiang

554 total citations
22 papers, 352 citations indexed

About

Maolin Jiang is a scholar working on Biomedical Engineering, Biomaterials and Molecular Biology. According to data from OpenAlex, Maolin Jiang has authored 22 papers receiving a total of 352 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Biomedical Engineering, 8 papers in Biomaterials and 7 papers in Molecular Biology. Recurrent topics in Maolin Jiang's work include Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Maolin Jiang is often cited by papers focused on Nanoplatforms for cancer theranostics (15 papers), Nanoparticle-Based Drug Delivery (8 papers) and Cancer, Hypoxia, and Metabolism (5 papers). Maolin Jiang collaborates with scholars based in China, India and Russia. Maolin Jiang's co-authors include Youyong Yuan, Kewei Wang, Qingyu Zong, Xuan Xiao, Ye Liu, Yalan Tu, Yao Wang, Yansong Dong, Xinqing Jiang and Shi‐Wei Luo and has published in prestigious journals such as Advanced Materials, Nano Letters and ACS Nano.

In The Last Decade

Maolin Jiang

20 papers receiving 349 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maolin Jiang China 12 239 127 126 85 52 22 352
Debabrata Dutta China 11 241 1.0× 133 1.0× 96 0.8× 130 1.5× 36 0.7× 13 379
Jiaxi Xu China 12 211 0.9× 185 1.5× 117 0.9× 71 0.8× 40 0.8× 19 346
Danika Rodrigues United States 8 206 0.9× 125 1.0× 140 1.1× 50 0.6× 29 0.6× 10 417
Guanqing Yang China 12 245 1.0× 256 2.0× 155 1.2× 80 0.9× 35 0.7× 17 498
Junha Lim South Korea 10 242 1.0× 86 0.7× 106 0.8× 64 0.8× 23 0.4× 16 354
Hyeongmok Park South Korea 8 239 1.0× 165 1.3× 227 1.8× 103 1.2× 45 0.9× 10 447
Qingyu Zong China 15 345 1.4× 187 1.5× 182 1.4× 132 1.6× 82 1.6× 25 529
Mohammad Ramezani Iran 7 258 1.1× 291 2.3× 210 1.7× 70 0.8× 49 0.9× 18 505
Zhihuan Liao China 9 213 0.9× 117 0.9× 118 0.9× 86 1.0× 18 0.3× 17 366

Countries citing papers authored by Maolin Jiang

Since Specialization
Citations

This map shows the geographic impact of Maolin Jiang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maolin Jiang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maolin Jiang more than expected).

Fields of papers citing papers by Maolin Jiang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maolin Jiang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maolin Jiang. The network helps show where Maolin Jiang may publish in the future.

Co-authorship network of co-authors of Maolin Jiang

This figure shows the co-authorship network connecting the top 25 collaborators of Maolin Jiang. A scholar is included among the top collaborators of Maolin Jiang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maolin Jiang. Maolin Jiang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jiang, Maolin, Ye Liu, Kewei Wang, et al.. (2025). Mutually reinforced activatable NIR fluorescence/MR bimodal imaging enabled by tumor-specific biomarker amplification. 1(4). 100044–100044. 2 indexed citations
2.
Wang, Xingguo, Zhixuan Liu, Yonggui Wang, Xianggang Zhang, & Maolin Jiang. (2025). Impact behavior of recycled aggregate concrete modified with nano-silica and fiber. Scientific Reports. 15(1). 19137–19137. 2 indexed citations
3.
Li, Guoliang, et al.. (2025). Associations between cardiometabolic index with kidney stones: evidence from NHANES 2007-2018. Frontiers in Endocrinology. 16. 1485477–1485477. 1 indexed citations
5.
Zheng, Sujun, Na Li, Maolin Jiang, et al.. (2025). Tumor-selective degradation of PARP-1 enabled by the codelivery of β-lapachone and PROTAC for non-small-cell lung cancer therapy. Nano Research. 19(1). 94908191–94908191.
6.
Wang, Kewei, Maolin Jiang, Ye Liu, et al.. (2024). A Synergistic Chemoimmunotherapy System Leveraging PD‐L1 Blocking and Bioorthogonal Prodrug Activation. Advanced Materials. 36(30). e2402322–e2402322. 16 indexed citations
7.
Zong, Qingyu, Maolin Jiang, Wenjie Tang, et al.. (2024). Self-assembled metal–phenolic network nanoparticles for delivery of a cisplatin prodrug for synergistic chemo-immunotherapy. Biomaterials Science. 12(14). 3649–3658. 4 indexed citations
8.
Dong, Yansong, Yalan Tu, Ye Liu, et al.. (2023). Perivascular nanocarrier aggregation as a drug reservoir augments tumor drug delivery and treatment efficacy. Nano Today. 53. 102004–102004. 3 indexed citations
9.
Liu, Ye, et al.. (2023). Cyclic amplification of intracellular ROS boosts enzymatic prodrug activation for enhanced chemo-immunotherapy. Acta Biomaterialia. 166. 567–580. 12 indexed citations
10.
Zong, Qingyu, et al.. (2023). Dual stimulus-triggered bioorthogonal nanosystem for spatiotemporally controlled prodrug activation and near-infrared fluorescence imaging. Chemical Communications. 59(26). 3878–3881. 14 indexed citations
11.
Wang, Kewei, Maolin Jiang, Yansong Dong, et al.. (2022). Spatial specific delivery of combinational chemotherapeutics to combat intratumoral heterogeneity. Journal of Controlled Release. 348. 1004–1015. 8 indexed citations
12.
Jiang, Maolin, Ye Liu, Yansong Dong, Kewei Wang, & Youyong Yuan. (2022). Bioorthogonal chemistry and illumination controlled programmed size-changeable nanomedicine for synergistic photodynamic and hypoxia-activated therapy. Biomaterials. 284. 121480–121480. 24 indexed citations
13.
Yu, Yi, Jie Wu, Zhongyue Li, et al.. (2022). Efficacy and Safety of Shenqu Xiaoshi Oral Liquid Compared With Domperidone Syrup in Children With Functional Dyspepsia. Frontiers in Pharmacology. 13. 831912–831912. 2 indexed citations
15.
Zong, Qingyu, Kewei Wang, Xuan Xiao, et al.. (2021). Amplification of tumor oxidative stresses by Poly(disulfide acetal) for multidrug resistance reversal. Biomaterials. 276. 121005–121005. 34 indexed citations
16.
Zong, Qingyu, et al.. (2021). Dual-locking nanoprobe based on hemicyanine for orthogonal stimuli-triggered precise cancer imaging and therapy. Journal of Controlled Release. 338. 307–315. 17 indexed citations
17.
Liu, Ye, Maolin Jiang, Yalan Tu, et al.. (2021). Time-programmed activation of dual polyprodrugs for synergistic cascade oxidation-chemotherapy. Biomaterials. 278. 121136–121136. 18 indexed citations
18.
Jiang, Maolin, Kewei Wang, Xuan Xiao, et al.. (2021). Theranostic Heterodimeric Prodrug with Dual‐Channel Fluorescence Turn‐On and Dual‐Prodrug Activation for Synergistic Cancer Therapy. Advanced Healthcare Materials. 10(21). e2101144–e2101144. 14 indexed citations
19.
Tu, Yalan, Shi‐Wei Luo, Xuan Xiao, et al.. (2021). Dual-Drug Backboned Polyprodrug with a Predefined Drug Combination for Synergistic Chemotherapy. Nano Letters. 21(5). 2216–2223. 57 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026